The cataractogenic activity of chemical agents.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000477:Alkylating Agents / Q000009:adverse effects; D000814:Aniline Compounds / Q000009:adverse effects; D002241:Carbohydrates / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced* / Q000503:physiopathology; D055598:Chemical Phenomena; D002621:Chemistry; D002746:Chlorpromazine / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D003276:Contraceptives, Oral; D004121:Dimethyl Sulfoxide / Q000009:adverse effects; D004140:Dinitrophenols / Q000009:adverse effects; D004178:Diquat / Q000009:adverse effects; D005123:Eye / Q000033:anatomy & histology; D006801:Humans; D006827:Hydantoins / Q000009:adverse effects; D007461:Iodoacetates / Q000009:adverse effects; D007908:Lens, Crystalline / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D009005:Monosaccharides / Q000009:adverse effects; D009281:Naphthalenes / Q000009:adverse effects; D013045:Species Specificity; D013311:Streptozocin / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013566:Sympathomimetics / Q000633:toxicity; D014308:Triparanol / Q000009:adverse effects; D014443:Tyrosine / Q000009:adverse effects
D000305:Adrenal Cortex Hormones; D000477:Alkylating Agents; D000814:Aniline Compounds; D002241:Carbohydrates; D002800:Cholinesterase Inhibitors; D003276:Contraceptives, Oral; D004140:Dinitrophenols; D006827:Hydantoins; D007461:Iodoacetates; D009005:Monosaccharides; D009281:Naphthalenes; D013449:Sulfonamides; D013566:Sympathomimetics; D014443:Tyrosine; D013311:Streptozocin; D014308:Triparanol; D004178:Diquat; D002746:Chlorpromazine; D004121:Dimethyl Sulfoxide